This prospective, single-center observational study, conducted at Careggi University Hospital in Florence, investigated the incidence and clinical predictors of cognitive decline in older patients with atrial fibrillation (AF) receiving oral anticoagulant therapy. The study included 140 patients aged ≥65 years without cognitive impairment at baseline. Over a mean follow-up of 1.9 years, 30 patients (26.5% of those reassessed) developed cognitive decline, corresponding to an incidence rate of 139.9 cases per 1,000 person-years, approximately twice that reported in the general older population. Multivariable analysis identified ischemic heart disease, previous stroke, and diabetes mellitus as independent predictors of cognitive decline, whereas higher educational attainment and better baseline cognitive performance were associated with a lower risk. These findings highlight the substantial burden of cognitive decline among older anticoagulated patients with AF and emphasize the importance of vascular comorbidities. They also support the integration of regular cognitive assessments and comprehensive cardiovascular risk factor management into the clinical care of this population.
Incidence and clinical predictors of cognitive decline in anticoagulated patients with atrial fibrillation: the Strat-AF Study / Di Carlo, A., Parenti, C., Barucci, E., Salti, G., Salvadori, E., Redi, G., Formelli, B., Fratini, F., Gori, A.M., Pracucci, G., Baldereschi, M., Meucci, F., Berteotti, M., Alfano, F., Ginestroni, A., Fainardi, E., Marcucci, R., Poggesi, A.. - In: EUROPACE. - ISSN 1532-2092. - ELETTRONICO. - 28:(2026), pp. euag168.1-euag168.4. [10.1093/europace/euag168]
Incidence and clinical predictors of cognitive decline in anticoagulated patients with atrial fibrillation: the Strat-AF Study
Barucci, Eleonora;Salti, Giulia;Salvadori, Emilia;Formelli, Benedetta;Fratini, Filippo;Gori, Anna Maria;Pracucci, Giovanni;Baldereschi, Marzia;Berteotti, Martina;Alfano, Francesco;Ginestroni, Andrea;Fainardi, Enrico;Marcucci, Rossella;Poggesi, Anna
2026
Abstract
This prospective, single-center observational study, conducted at Careggi University Hospital in Florence, investigated the incidence and clinical predictors of cognitive decline in older patients with atrial fibrillation (AF) receiving oral anticoagulant therapy. The study included 140 patients aged ≥65 years without cognitive impairment at baseline. Over a mean follow-up of 1.9 years, 30 patients (26.5% of those reassessed) developed cognitive decline, corresponding to an incidence rate of 139.9 cases per 1,000 person-years, approximately twice that reported in the general older population. Multivariable analysis identified ischemic heart disease, previous stroke, and diabetes mellitus as independent predictors of cognitive decline, whereas higher educational attainment and better baseline cognitive performance were associated with a lower risk. These findings highlight the substantial burden of cognitive decline among older anticoagulated patients with AF and emphasize the importance of vascular comorbidities. They also support the integration of regular cognitive assessments and comprehensive cardiovascular risk factor management into the clinical care of this population.I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.



